Indefinite Delivery Contract 36C25625D0057

Award Date 6/23/25
Last Date to Order 6/1/30
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick, a civilian agency, to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The $99,032,828.20 multiple-award IDC provides national access to germline genetic testing for oncology, medical genetics, and pharmacogenomic testing for VA patients through September 2029. The IDC includes a $2,300,000 fixed-price task order for "GERMLINE PGX...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Michael E. DeBakey VA Medical Center (MEDVAMC) Pathology & Laboratory Medicine Service, to Ailife Diagnostics, Inc., a woman-owned small business. The contract, valued at up to $1,121,500.00, is for the provision of comprehensive physician-authorized genetic testing services to support the diagnosis and medical management of veteran patients. The contract includes over 200...
The Department of Veterans Affairs Veterans Health Administration has awarded a single-award Indefinite Delivery Contract (IDC) worth $1,140,000 to Broad Clinical Laboratories, LLC of Cambridge, Massachusetts. This IDC has a period of performance through February 6, 2029 and is designed to provide genetic testing services to VA medical facilities within Veterans Integrated Service Network 1, which covers northern New England. Under the initial $270,000 firm fixed price delivery order, Broad...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to PreventionGenetics LLC for germline genetic testing services. Under multiple task orders from September 2021 through September 2024, PreventionGenetics will provide testing to support VA healthcare programs from its facilities in Salt Lake City, Utah. The single award agreement has a potential value of $6.9 million. PreventionGenetics will utilize its...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Infinity Biologix LLC, doing business as Sampled Division, for genomic analysis services worth up to $86.5 million over the period of performance ending September 29, 2025. This single-award IDC was issued by the VA Headquarters and does not include any socioeconomic set-asides. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders to Infinity Biologix for genomic sequencing, DNA...
This federal Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including the GeneXpert testing platform. The single-award IDC, valued up to $1,500,000, is for the procurement of GeneXpert test kits, reagents, and associated maintenance and support services. This IDC enables the VA to continuously acquire Cepheid's molecular diagnostic products and...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Genomind Inc. The contract, valued at up to $225,000.00, is for 621 II, MEDICAL LABORATORY TESTING & ANALYSIS SERVICES and has a period of performance through May 31, 2030. As an FSS contract, this is a multiple award vehicle that allows the VA and other federal agencies to procure these medical laboratory testing and analysis services. The contract does not...
The Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick awarded an Indefinite Delivery, Indefinite Quantity (IDIQ) contract to Baylor Miraca Genetics Laboratories LLC, doing business as Baylor Genetics, for the provision of germline pharmacogenomics (PGx) molecular testing services. The $982,402.00 firm fixed-price task order has an ultimate completion date of September 29, 2025 and supports the VA's medical research and development efforts. This IDIQ contract is part of...
This indefinite delivery contract (IDC) was awarded by the Veterans Integrated Service Network 9 (VISN 9), a civilian federal agency, to Genben Lifesciences Corp, a woman-owned small business. The contract has a ceiling value of $56,810 and a period of performance through March 31, 2030. The purpose of this IDC is to provide specialty tests and receive corresponding results for the agency. The contract does not utilize any set-asides and was a single award. Based on the general description...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
  • 36C25625D0057
    Indefinite Delivery Contract
  • 1
    Federal Contract Awards

This federal Indefinite Delivery Contract (IDC) was awarded by the Veterans Integrated Service Network 16, a civilian agency under the Department of Veterans Affairs (VA), to Preventiongenetics LLC, a for-profit limited liability company specializing in advanced genetic testing services. The contract has a ceiling value of $1,719,533.16 and a period of performance through June 1, 2030.

The primary purpose of this IDC is to provide TESTING SERVICES FOR LAB SAMPLES to support the VA's healthcare initiatives. A $323,800 firm fixed price delivery order was issued under this IDC for TESTING SERVICES FOR PATIENT CARE, to be performed in Houston, TX. Preventiongenetics LLC has established itself as a trusted provider of genetic testing services to multiple federal agencies, including the VA and National Institutes of Health, supporting medical research, patient diagnostics, and healthcare programs. The company holds several Indefinite Delivery Vehicles with the VA and Department of the Army Medical Command, demonstrating its capability to deliver specialized genetic testing across different federal healthcare programs.

Generated 7/1/25, 12:36 PM